Douglas J. Robertson, MD, MPH
Title(s)
Professor of Medicine
Professor of The Dartmouth Institute
Department(s)
Medicine
The Dartmouth Institute
Education
Georgetown University, BS 1988
U. Connecticut School of Medicine, MD 1992
University of North Carolina, MPH 2000
Programs
The Dartmouth Institute for Health Policy and Clinical Practice
Websites
http:
Academic Analytics
View Profile
Contact Information
VA Medical Center
215 N Main St
Mail Code 111E
White River Junction VT 05009
Office: 802 295 9363
Phone: x5590
Professional Interests
Colorectal Cancer Epidemiology and Outcomes
Pharmacoepidemiology of GI disease
Grant Information
1.Prospective Evaluation of Risk Factors for Large (≥ 1cm) Colonic Adenomas in Asymptomatic Subjects. A large multicenter trial funded by the VA Cooperative Studies Program. Principal Investigator: David Lieberman. (Role: Site PI)
2.Translation of Colorectal Cancer Screening Guidelines to Practice-A System Intervention. A multicenter trial funded by the VA Colorectal Cancer Queri. Principal Investigator: Linda Humphrey. (Role Site PI)
3.Colorectal Chemoprevention with Calcium and Vitamin D. A large randomized placebo controlled trial funded by the National Institutes of Health. Principal Investigator: John Baron (Role Clinical Director)
4.Developing Sensible Screening Strategies Following Colonoscopy. VA Health Services Research & Development Career Development Award (Principal Investigator)
Courses Taught
Scientific Basis of Medicine-GI Section
Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults. Systematic scoping review: Use of the faecal immunochemical test residual buffer to enhance colorectal cancer screening. Colonoscopy vs the Fecal Immunochemical Test: Which is Best? Fecal Immunochemical Test Screening: Maximizing Success by Minimizing Failure. Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial. Understanding the Results of a Randomized Trial of Screening Colonoscopy. Response to Yoo and Sonnenberg & Braillon. Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer. Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. |
|